Pharmafile Logo
Pharmafocus logo
Advanced Search

SMC

Showing 15 posts of 37 posts found.

450px-flag_of_scotland

Scottish Medicines Consortium approves Revlimid for two groups of blood cancer patients

October 14, 2020
Research and Development Revlimid, SMC

The Scottish Medicines Consortium (SMC) has accepted Revlimid (lenalidomide) for routine use on NHS Scotland for patients with multiple myeloma …

News
bavencio

Bavencio/axitinib combo approved for NHS Scotland in advanced renal cell carcinoma

October 13, 2020
Manufacturing and Production, Sales and Marketing Merck, NHS, Pfizer, SMC

The Scottish Medicines Consortium (SMC) has given the go-ahead to Merck KGaA and Pfizer’s combination of their PD-L1 inhibitor immunotherapy …

News
160324-f-hc995-002

Scottish Medicines Consortium enables access to treatment for rare inherited bone disorder in children

February 18, 2020
Manufacturing and Production Crysvita, Kyowa Kirin, SMC, Scottish Medicine Consortium, nhs scotland

The Scottish Medicines Consortium (SMC) has enabled access to Kyowa Kirin’s Crysvita (burosumab) for the NHS in Scotland to treat …

News
five-clear-glass-vial-bottles

Scotland approves targetted combination therapy for advanced melanoma

February 11, 2020
Manufacturing and Production NHS, SMC, Scotland, UK, advanced melanoma, melanoma

The Scottish Medicines Consortium (SMC) has approved targeted combination therapy for the treatment of adult patient with unresectable or metastatic …

News
vertex-headquarters

Vertex cystic fibrosis drugs become available in Scotland after NHS rejection

September 12, 2019
Sales and Marketing SMC, Vertex, cystic fibrosis

Two potentially life-changing cystic fibrosis drugs are to become available for a potential pool of 400 patients in Scotland just …

News
merck-keytruda

MSD’s Keytruda approved for first-line lung cancer use on NHS Scotland

September 10, 2019
Manufacturing and Production, Sales and Marketing Cancer, MSD, SMC, Scotland, keytruda, lung cancer, pharma

MSD and lung cancer patients will be celebrating the news that the pharma giant’s immunotherapy Keytruda (pembrolizumab) has been accepted …

News
hiv_virus

SMC gives nod for access to new HIV treatment Dovato

September 10, 2019
Manufacturing and Production HIV, SMC

The Scottish Medicines Consortium (SMC) has approved Dovato (dolutegravir/lamivudine) for use on the NHS, allowing treatment of individuals with a …

News
vertex-headquarters

Scotland turns down Vertex’s Orkambi

August 13, 2019
Manufacturing and Production Orkambi, SMC, Scotland, Vertex, cystic fibrosis, pharma

The Scottish Medicines Consortium (SMC) has turned down Vertex’ cystic fibrosis drug Orkambi on the grounds that it is not …

News

Scottish Medicines Consortium rejects Novartis’ CAR T therapy Kymriah

March 12, 2019
Manufacturing and Production Kymriah, NICE, Novartis, SMC, Scotland, UK

Scotland’s cost effectiveness body has refused to fund Novartis’ CAR T therapy Kymriah for adult patients with lymphoma. The Scottish …

News
the_registered_head_office_of_santen_pharmaceutical_co

Scottish Medicines Consortium approves Verkazia for severe eye condition in children and adolescents

December 12, 2018
Research and Development, Sales and Marketing SMC, Santen, Scotland, UK, Verkazia, pharma, vernal keratoconjunctivitis

UK-based pharmaceutical firm Santen has announced that the Scottish Medicines Consortium has awarded approval to its eye drops emulsion Verkazia …

News
3922609891_dced293244_z

Rare lung cancer drug approved in Scotland

August 14, 2018
Manufacturing and Production Cancer, SMC, Scotland, Scottish Medicines Consortium, approval, lung cancer

The Scottish Medicines Consortium has approved Roche’s cancer drug alectinib for the treatment of patients with untreated advanced non-small-cell lung …

News
scotland_flag

SMC reverses decision on Opdivo for kidney cancer

June 12, 2017
Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, SMC, opdivo

The Scottish Medicines Consortium (SMC) has performed a U-turn on its decision regarding Opdivo (nivolumab), and will now allow patients …

News
janssen_latest_logo_on_sign_closer

Scotland recommends Janssen’s Imbruvica for leukaemia

April 11, 2017
Manufacturing and Production, Sales and Marketing SMC, imbruvica, leukaemia

Janssen has been celebrating the news that its Imbruvica (ibrutinib) has been recommended by the Scottish Medicines Consortium (SMC) for …

News
janssen_latest_logo_on_sign_closer

SMC rejects Janssen’s multiple myeloma treatment Darzalex

January 17, 2017
Manufacturing and Production, Sales and Marketing Janssen, SMC, darzalex

The Scottish Medicines Consortium (SMC) has decided not to recommend Janssen’s Darzalex (daratumumab) for routine use by NHS Scotland as …

News
nice_aerial

Lowered price wins NICE approval for Janssen leukaemia treatment

November 25, 2016
Medical Communications, Sales and Marketing Janssen, NICE, SMC, chronic lymphocytic leukaemia, ibrutinib, imbruvica

After being knocked back in the beginning of June this year, NICE has announced that Janssen’s Imbruvica (ibrutinib) will now …

News

Latest content

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024